Brett Kaplan insider trades

Open-market stock purchases and sales by Brett Kaplan, Chief Operating Officer at Climb Bio, Inc, from SEC Form 4 filings since Feb 19, 2020.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • CLYM Climb Bio, Inc: other filings, last Jan 13, 2025
  • ELYM Eliem Therapeutics, Inc: other filings, last Aug 26, 2024
  • CMPX Compass Therapeutics, Inc: other filings, last Feb 18, 2022
  • PRVL Prevail Therapeutics Inc: other filings, last Jan 22, 2021

Get free alerts when Brett Kaplan files a new trade →